2026 Southern Hemisphere Influenza Vaccine
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2DP25R0004
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking to procure approximately 60,000 doses of Southern Hemisphere Influenza Vaccine for the 2026-2027 flu season. The vaccines must be pre-measured 0.5 ML doses in pre-filled commercially available syringes for intramuscular administration in individuals aged 6 months and older. All vaccines must be FDA-approved and CDC Advisory Committee on Immunization Practices (ACIP) recommended, with the specific formula to be determined by the FDA's Vaccines and Related Biological Products Advisory Committee. The successful contractor must possess FDA approval and provide ACIP-recommended vaccines. The solicitation is projected to be released in September 2025, with responses due by September 2, 2025, and interested parties should contact Rosbert Jones at rosbert.jones@dla.mil for questions.
This procurement does not utilize any set-aside designation and no incumbent contractors are identified in the notice. The contract structure is proposed as an indefinite quantity contract with a guaranteed minimum of 75% of the annual estimate (approximately 45,000 doses) and a maximum of 150% (approximately 90,000 doses). All vaccine doses must be delivered to the Defense Depot in New Cumberland, Pennsylvania, with the contractor required to deliver 100% of requirements by March 16, 2026, though alternative delivery schedules will be considered. The opportunity falls under NAICS code 325414 for Biological Product Manufacturing and PSC code 6505 for Drugs and Biologicals. National Stock Numbers will be established at the time of contract award, and quantities may fluctuate based on final Service requirements.
Notice text
The Defense Logistics Agency Troop Support is soliciting for the supply of Southern Hemisphere Influenza Vaccine for the 2026-2027 flu season. Approximately 60,000 doses are included in this requirement. (Quantities may increase or decrease pending receipt of final Service requirements.) The vaccines shall be a pre-measured 0.5 ML dose, each dose shall be pre-filled in a commercially available syringe for intramuscular administration in healthy individuals aged 6 months and older. The vaccine shall be U.S. Food & Drug Administration (FDA)-approved and U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) recommended.
The formula for the 2026-2027 season vaccine shall be determined by the FDA’s Vaccines and Related Biological Products Advisory Committee. Other specification data is included in the solicitation. Successful contractor must have FDA Approval and the vaccine must be ACIP recommended. National Stock Numbers shall be established at time of award.
An indefinite quantity contract is proposed. The quantity indicated is an annual estimate only. (Quantities may increase or decrease pending receipt of final Service requirements.) The guaranteed minimum will be 75% of the annual estimate, and a contract maximum will be established at 150% of the annual estimate.
All quantities shall be delivered to the Defense Depot New Cumberland, PA. The contractor shall be capable of delivering 100% of the requirements by March 16, 2026. This delivery schedule is the preferred delivery schedule. Other delivery schedules will be considered.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://www.sam.gov. Interested parties should contact Rosbert Jones (rosbert.jones@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of presolicitation or solicitation changes through this website. The current projected solicitation date is September of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2026 Southern Hemisphere Influenza Vaccine | Limited / Sole Source Justification | |
| 2026 Southern Hemisphere Influenza Vaccine | Solicitation | |
| This notice | Pre-Solicitation | |
| 2026 Southern Hemisphere Influenza Vaccine | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity